Asbestos included in EPA’s first list of chemicals to evaluate for safety concerns

2 Dec 2016 by Sarah Mahan under News

EPA logo 100x100 Asbestos included in EPAs first list of chemicals to evaluate for safety concernsIn June, President Barack Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act into law as an amendment to the Toxic Substances Control Act (TSCA), the U.S.’s primary chemical management law. It marked the first time American chemical regulatory law had been updated in nearly 40 years.

Read the rest of this entry »


Estimated asbestos injury liability payout costs hit $100 million

30 Nov 2016 by Sarah Mahan under News

GHS pictogram silhouette.svg 1 edited 100x100 Estimated asbestos injury liability payout costs hit $100 millionThe cost of asbestos continues to add up.

Cost estimates to property/casualty insurers due to third party liability asbestos claims has jumped from $85 billion to $100 billion within just four years. A.M. Best, a global insurance credit rating and information service, adjusted its estimates earlier this week based on historic trends, like increases in the cost of care and life expectancies. Read the rest of this entry »


Asbestos-related cancers plague Kenya

29 Nov 2016 by Sarah Mahan under News

Kenya Nairobi area Wikimedia Commons 100x100 Asbestos related cancers plague KenyaThough Kenya banned the use of asbestos in 2006, it is one of many lower-income countries still struggling with its impacts. Nearly all its government institutions, including educational facilities and residential estates built in the 1950s and 1960s, still have asbestos roofs. The Kenyan government is spending nearly 10 percent of its health budget of $330 million on treating asbestos-related cancers, according to the Global Construction Review.

Read the rest of this entry »


November marks Australian Asbestos Awareness Month

23 Nov 2016 by Sarah Mahan under News

meso awareness products for web 150x150 November marks Australian Asbestos Awareness MonthAs November comes to an end, so too does Australia’s Asbestos Awareness Month. Australians across the country have been participating in an Asbestos Awareness campaign, overseen by a combination of government agencies and research and preventative initiatives, throughout the month of November.

Read the rest of this entry »


Canada moves nearer to asbestos ban under pressure from labor union

22 Nov 2016 by Sarah Mahan under News

canada flag Canada moves nearer to asbestos ban under pressure from labor union is planning to join more than 50 countries that have already placed bans on asbestos, a heat-resistant silicate mineral linked to the development of , according to science, research and technology news service Phys.org.

A bill presented in the Canadian House of Commons Wednesday would completely ban the substance connected to , a rare cancer affecting the lining of the lungs and chest, the abdomen, and, rarely, the heart. The New Democrats, ’s largest union, presented the bill after Canadian Prime Minister Justin Trudeau pledged to ban asbestos five months ago. Read the rest of this entry »


Study: Chemotherapy, combination treatments add time to life expectancies of mesothelioma patients

21 Nov 2016 by Sarah Mahan under Research/Treatment

research test tubes 100x100 Study: Chemotherapy, combination treatments add time to life expectancies of mesothelioma patientsFor those diagnosed with , treatment is usually based on the stage and type of the cancer.

Recent study results show that chemotherapy and multimodal treatment — using multiple methods of treatment, specifically the combination of chemotherapy and surgery — results in longer life expectancy in patients with . Read the rest of this entry »


Cancer vaccine being tested for mesothelioma treatment gains patent in Europe, trials continue

16 Nov 2016 by Sarah Mahan under Research/Treatment

research test tubes 100x100 Cancer vaccine being tested for mesothelioma treatment gains patent in Europe, trials continueA cancer vaccine being clinically tested in patients continues to gain traction.

Earlier this month, Targovax, the immune-oncology company developing the vaccine, acquired a European patent for its new ONCOS-102 product after receiving a patent for the cancer vaccine in May from the United States.

The vaccine, now in the beginning trial stages, generates viruses, called oncolytic viruses, that specifically target and infect cancer cells and function as immune activators. A previous Phase I trial reported ONCOS-102 treatment induced tumor-specific immune activation both at a systemic and lesional level in tumors of late stage cancer patients. Read the rest of this entry »


Sydney Harbour Bridge project uncovered asbestos; public made aware 10 months later

15 Nov 2016 by Temp Temple under News

Sydney Harbour Bridge Wikipedia 100x100 Sydney Harbour Bridge project uncovered asbestos; public made aware 10 months laterAfter road workers in Australia completed construction and renovation on the Sydney Harbour Bridge nearly 10 months ago, the public has just been made aware of the discovery of asbestos beneath concrete slabs on the structure.

According to Daily Mail Australia, Duncan Gay, the NSW Nationals Minister for Roads and also a qualified hygienist, was only told of the asbestos earlier this month. Fortunately for those living nearby the bridge, Gay did confirm that the asbestos had low potential for airborne exposure. Local authorities will also be investigating where the excess material taken from the site went and whether or not it was disposed of properly. Read the rest of this entry »


New Australian research suggests mesothelioma tumors grow blood vessels

14 Nov 2016 by Sarah Mahan under Research/Treatment

research test tubes 100x100 New Australian research suggests mesothelioma tumors grow blood vessels may be growing differently than experts previously believed.

A recent discovery by researchers at Australia’s Flinders University suggests tumors promote growth through creating blood vessels, defying available medical treatments for the cancer.
Existing treatments target blood vessels that grow into a tumor, not those that develop from within a tumor. Read the rest of this entry »


Asbestos removal class action in Kansas City settles for $80M

28 Oct 2016 by Temp Temple under Legal

Gavel Scales of Justice American flag square 100x100 Asbestos removal class action in Kansas City settles for $80MA class action lawsuit involving a nearly 30-year-old asbestos removal project in City, Kan., and about 7,500 exposed claimants has been settled for $80 million. Despite being scheduled to go to trial this week, the county ended up reaching an agreement with the group responsible for the asbestos removal, U.S. Engineering.

The $80 million settlement agreed upon will be divided up with $25 million for attorney’s fees and litigation costs and the remainder for a medical monitoring fund for the claimants. As many asbestos experts know, there is no safe level of exposure to asbestos. The medical fund would allow those who were exposed to asbestos from 1983 to 1985 in the Jackson County Courthouse to be eligible for diagnostic tests monitoring their status in case an asbestos-related disease was to occur. Read the rest of this entry »